Sunday, June 13, 2021 3:59:03 PM
If the above is true, I believe you have a scenario in which production can catch up with demand as long as proper preparations are made at the time of the surgery. If the tumor, or tumor lysate, can be properly preserved at the time of the surgery I don't believe there is an immediate need to make DCVax-L. I'm frankly uncertain if it's best to do the leukapheresis before the removal of the tumor, or just before making the DCVax-L, or any time in between. If it's of greater benefit to do it before the surgery, it too can be done and preserved.
As I understand it, with a cell line it takes just over a week to make the DCVax-L, it may be slightly faster with the Flaskwork device. What's important is that the necessary products are preserved properly, then production can be scheduled as ever greater capacity is being added post approval.
I frankly believe that CRL is capable of rapidly gearing up. While it's very possible that hundreds, or even thousands of tumors will be properly preserved in anticipation of approval, the key will be, can we get them into the roughly one week production cycle while they can still be of benefit, perhaps up to six months or more after surgery, depending on the condition of the patient at that time. I believe that CRL has substantial clean room capacity, the question is, how much of it can be devoted to production of DCVax-L.
To me, the joker in the deck is the Flaskwork device, and the regulators willingness to use it if capacity is lacking. Let's say we had the capacity to handle 900 patients, but 1000 patients were fighting for it. 25 Flaskwork devices and 100 cassettes could make up for the lacking capacity in one month. Would the regulators permit the 100 patients to be treated in a timely way and work on certifying the devices simultaneously, or not. I tend to think different regulators will act differently, but that at least some will benefit from the use of the Flaskwork device.
Once it's determined that the Flaskwork device is qualified to make DCVax-L, production capacity problems should be eliminated.
Gary
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/03/2024 08:01:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:01:24 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2024 09:06:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:30:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/02/2024 02:42:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM